Hikma Pharmaceuticals (GB:HIK) has released an update.
Hikma Pharmaceuticals PLC has announced that as of June 30, 2024, the company’s issued share capital consists of 221,886,453 Ordinary Shares, each with voting rights, excluding the 12,833,233 Shares held in treasury which do not carry voting rights. Shareholders can use this total figure as a basis for reporting changes in ownership or interest in the company.
For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.
